Finance

Beta
Ask
Lists
KPRX:NASDAQ
Kiora Pharmaceuticals Inc
$2.55
-1.92%
(-0.050) 1D
Jun 12, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KPRX...
Open
$2.59
High
$2.59
Low
$2.54
Mkt. cap
11.30M
Avg. vol.
51.86K
Volume
23.78K
52-wk high
$3.29
52-wk low
$1.76
EPS
-$2.68
Beta
-0.40
Shares outstanding
4.43M
No. of employees
13
Open
$2.59
High
$2.59
Low
$2.54
Mkt. cap
11.30M
Avg. vol.
51.86K
Volume
23.78K
52-wk high
$3.29
52-wk low
$1.76
EPS
-$2.68
Beta
-0.40
Shares outstanding
4.43M
No. of employees
13
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to KPRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for KPRX in the last 3 months.
Highest
Current $2.55
$12.00 (+370.59%)
Average
$12.00 (+370.59%)
Lowest
$12.00 (+370.59%)
News stories
From sources across the web
About Kiora Pharmaceuticals Inc
CEO-
Employees13
Founded1998
HeadquartersEncinitas, California, United States
SectorPharmaceutical industry
Websitekiorapharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
904.57K
1.07M
1.17M
-
Cost of revenue
904.57K
1.07M
1.17M
-
Research and development expenses
-
-
-
890.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.35M
1.44M
1.46M
1.61M
Operating expense
1.35M
1.44M
1.46M
2.50M
Total operating expenses
2.26M
2.52M
2.63M
2.50M
Operating income
-2.26M
-2.52M
-2.63M
-2.50M
Other non operating income
-93.56K
-23.71K
173.24K
-47.13K
EBT including unusual items
-2.26M
-616.32K
-7.17M
-2.42M
EBT excluding unusual items
-2.13M
-2.34M
-2.49M
-2.41M
Income tax expense
-112.06K
-643.13K
-649.97K
-
Effective tax rate
4.95%
104.35%
9.07%
-
Other operating expenses
-
-
-
-
Net income
-2.15M
26.81K
-6.52M
-2.42M
Net profit margin
-
-
-
-
Earnings per share
-0.54
0.01
-
-
Interest and investment income
225.24K
201.82K
190.31K
139.34K
Interest expense
-
-
-19.96K
-
Net interest expenses
225.24K
201.82K
170.35K
139.34K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.25M
-2.50M
-2.62M
-2.49M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer